Aerovate Therapeutics Analyst Ratings
BenzingaApr 1 12:05 ET
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Aerovate Therapeutics (AVTE) and Delcath Systems (DCTH)
TipRanksMar 27 06:10 ET
Aerovate Therapeutics Analyst Ratings
BenzingaMar 25 08:37 ET
TD Cowen Sticks to Its Buy Rating for Aerovate Therapeutics (AVTE)
TipRanksFeb 26 07:36 ET
Aerovate Therapeutics (AVTE) Receives a Buy From BTIG
TipRanksJan 2 09:08 ET
Buy Rating Affirmed: Aerovate Therapeutics' AV-101 Shows Strong Potential Amid Successful IMPAHCT Trial Progression
TipRanksNov 27, 2023 11:35 ET
Analysts' Top Healthcare Picks: Aerovate Therapeutics (AVTE), Calidi Biotherapeutics (CLDI)
TipRanksNov 22, 2023 06:20 ET
Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET) and Aerovate Therapeutics (AVTE)
TipRanksNov 14, 2023 01:50 ET
TD Cowen Sticks to Their Buy Rating for Aerovate Therapeutics (AVTE)
TipRanksNov 13, 2023 10:16 ET
Wedbush Adjusts Aerovate Therapeutics Price Target to $48 From $50, Maintains Outperform Rating
MT NewswiresAug 15, 2023 11:04 ET
Analysts Are Bullish on Top Healthcare Stocks: Aerovate Therapeutics (AVTE), Antibe Therapeutics (ATBPF)
TipRanksAug 15, 2023 10:30 ET
Aerovate Therapeutics (AVTE) Gets a Buy From Jefferies
TipRanksAug 15, 2023 09:05 ET
Wedbush Lowers Aerovate Therapeutics' Price Target to $50 From $54, Keeps Outperform Rating
MT NewswiresMay 17, 2023 07:12 ET
Aerovate Therapeutics (AVTE) Receives a Buy From Wedbush
TipRanksMay 17, 2023 06:55 ET
Analysts Offer Insights on Healthcare Companies: LumiraDx (LMDX) and Aerovate Therapeutics (AVTE)
TipRanksMay 16, 2023 20:50 ET
Analysts Offer Insights on Healthcare Companies: Prothena (PRTA), Y-Mabs Therapeutics (YMAB) and Aerovate Therapeutics (AVTE)
TipRanksApr 1, 2023 09:11 ET
Aerovate Therapeutics (AVTE) Receives a Buy From Wedbush
TipRanksMar 30, 2023 09:38 ET
Guggenheim Initiates Coverage On Aerovate Therapeutics With Buy Rating, Announces Price Target of $36
BenzingaMar 1, 2023 05:27 ET
Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Aerovate Therapeutics (AVTE)
TipRanksDec 12, 2022 07:05 ET
Wedbush Remains a Buy on Aerovate Therapeutics (AVTE)
TipRanksDec 7, 2022 07:35 ET
No Data
No Data